Advertisement
Advertisement

APUS

APUS logo

Apimeds Pharmaceuticals US, Inc.

4.24
USD
Sponsored
+0.01
+0.24%
Aug 10, 16:00 UTC -4
Closed
exchange

After-Market

4.81

+0.57
+13.40%

Apimeds Pharmaceuticals US, Inc. Profile

About

Apimeds Pharmaceuticals US Inc. operates as a clinical stage biopharmaceutical company. It researches, develops, manufactures, commercializes and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. Apimeds Pharmaceuticals US Inc. is based in Hopewell, New Jersey.

Info & Links

CEO

Vin Menon

Headquarters

100 MATAWAN RD, SUITE 325
MATAWAN, NJ 07747, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://www.apimedsus.com

Auditor

Kreit & Chiu CPA LLP

Share holders

--

Employees

7

Apimeds Pharmaceuticals US, Inc. Statistics

Valuation Measures

Market Capitalization2

7.26M

Enterprise Value

7.64M

Enterprise Value/EBITDA(ttm)

-0.32

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.04

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-54.65%

Return on Invested Capital(ttm)

-77.63%

Return on Assets(ttm)

-50.01%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-23.70M

Net Income Available to Common(ttm)

-40.66M

Diluted EPS(ttm)

-27.40

Share Statistics

Beta (5Y Monthly)

0.16

52-Week Change

-73.33%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

1.51M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

10.48M

Total Cash Per Share(mrq)

6.94

Total Debt(mrq)

9.36M

Total Debt/Equity(mrq)

7.40%

Current Ratio(mrq)

0.90%

Quick Ratio(mrq)

0.90%

Book Value Per Share(mrq)

100.60

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.33

Free Cash Flow(ytd)

-2.08M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement